Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life

Introduction. In a degenerative disorder such as Parkinson’s disease (PD), it is important to establish clinical stages that allow to know the course of the disease. Our aim was to analyze whether a scale combining Hoehn and Yahr’s motor stage (H&Y) and the nonmotor symptoms burden (NMSB) (asses...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Santos García, T. De Deus Fonticoba, J. M. Paz González, C. Cores Bartolomé, L. Valdés Aymerich, J. G. Muñoz Enríquez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, L. L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. A. Ávila Rivera, M. J. Catalán, V. Nogueira, V. Puente, J. M. García Moreno, C. Borrué, B. Solano Vila, M. Álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J. C. Martínez Castrillo, P. Sánchez Alonso, M. G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez Estrada, M. Seijo, J. Rúiz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González Ardura, C. Ordás, L. López Díaz, P. Mir, P. Martinez-Martin, COPPADIS Study Group
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2021/8871549
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849411855067381760
author D. Santos García
T. De Deus Fonticoba
J. M. Paz González
C. Cores Bartolomé
L. Valdés Aymerich
J. G. Muñoz Enríquez
E. Suárez
S. Jesús
M. Aguilar
P. Pastor
L. L. Planellas
M. Cosgaya
J. García Caldentey
N. Caballol
I. Legarda
J. Hernández Vara
I. Cabo
L. López Manzanares
I. González Aramburu
M. A. Ávila Rivera
M. J. Catalán
V. Nogueira
V. Puente
J. M. García Moreno
C. Borrué
B. Solano Vila
M. Álvarez Sauco
L. Vela
S. Escalante
E. Cubo
F. Carrillo Padilla
J. C. Martínez Castrillo
P. Sánchez Alonso
M. G. Alonso Losada
N. López Ariztegui
I. Gastón
J. Kulisevsky
M. Blázquez Estrada
M. Seijo
J. Rúiz Martínez
C. Valero
M. Kurtis
O. de Fábregues
J. González Ardura
C. Ordás
L. López Díaz
P. Mir
P. Martinez-Martin
COPPADIS Study Group
author_facet D. Santos García
T. De Deus Fonticoba
J. M. Paz González
C. Cores Bartolomé
L. Valdés Aymerich
J. G. Muñoz Enríquez
E. Suárez
S. Jesús
M. Aguilar
P. Pastor
L. L. Planellas
M. Cosgaya
J. García Caldentey
N. Caballol
I. Legarda
J. Hernández Vara
I. Cabo
L. López Manzanares
I. González Aramburu
M. A. Ávila Rivera
M. J. Catalán
V. Nogueira
V. Puente
J. M. García Moreno
C. Borrué
B. Solano Vila
M. Álvarez Sauco
L. Vela
S. Escalante
E. Cubo
F. Carrillo Padilla
J. C. Martínez Castrillo
P. Sánchez Alonso
M. G. Alonso Losada
N. López Ariztegui
I. Gastón
J. Kulisevsky
M. Blázquez Estrada
M. Seijo
J. Rúiz Martínez
C. Valero
M. Kurtis
O. de Fábregues
J. González Ardura
C. Ordás
L. López Díaz
P. Mir
P. Martinez-Martin
COPPADIS Study Group
author_sort D. Santos García
collection DOAJ
description Introduction. In a degenerative disorder such as Parkinson’s disease (PD), it is important to establish clinical stages that allow to know the course of the disease. Our aim was to analyze whether a scale combining Hoehn and Yahr’s motor stage (H&Y) and the nonmotor symptoms burden (NMSB) (assessed by the nonmotor symptoms scale (NMSS)) provides information about the disability and the patient’s quality of life (QoL) with regard to a defined clinical stage. Materials and Methods. Cross-sectional study in which 603 PD patients from the COPPADIS cohort were classified according to H&Y (1, stage I; 2, stage II; 3, stage III; 4, stage IV/V) and NMSB (A: NMSS = 0–20; B: NMSS = 21–40; C: NMSS = 41–70; D: NMSS ≥ 71) in 16 stages (HY.NMSB, from 1A to 4D). QoL was assessed with the PDQ-39SI, PQ-10, and EUROHIS-QOL8 and disability with the Schwab&England ADL (Activities of Daily Living) scale. Results. A worse QoL and greater disability were observed at a higher stage of H&Y and NMSB (p<0.0001). Combining both (HY.NMSB), patients in stages 1C and 1D and 2C and 2D had significantly worse QoL and/or less autonomy for ADL than those in stages 2A and 2B and 3A and 3B, respectively (p<0.005; e.g., PDQ-39SI in 1D [n = 15] vs 2A [n = 101]: 28.6 ± 17.1 vs 7.9 ± 5.8; p<0.0001). Conclusion. The HY.NMSB scale is simple and reflects the degree of patient involvement more accurately than the H&Y. Patients with a lower H&Y stage may be more affected if they have a greater NMS burden.
format Article
id doaj-art-59a6353979e04f60ae4c6dfc6d5fa628
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-59a6353979e04f60ae4c6dfc6d5fa6282025-08-20T03:34:40ZengWileyParkinson's Disease2090-80832042-00802021-01-01202110.1155/2021/88715498871549Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of LifeD. Santos García0T. De Deus Fonticoba1J. M. Paz González2C. Cores Bartolomé3L. Valdés Aymerich4J. G. Muñoz Enríquez5E. Suárez6S. Jesús7M. Aguilar8P. Pastor9L. L. Planellas10M. Cosgaya11J. García Caldentey12N. Caballol13I. Legarda14J. Hernández Vara15I. Cabo16L. López Manzanares17I. González Aramburu18M. A. Ávila Rivera19M. J. Catalán20V. Nogueira21V. Puente22J. M. García Moreno23C. Borrué24B. Solano Vila25M. Álvarez Sauco26L. Vela27S. Escalante28E. Cubo29F. Carrillo Padilla30J. C. Martínez Castrillo31P. Sánchez Alonso32M. G. Alonso Losada33N. López Ariztegui34I. Gastón35J. Kulisevsky36M. Blázquez Estrada37M. Seijo38J. Rúiz Martínez39C. Valero40M. Kurtis41O. de Fábregues42J. González Ardura43C. Ordás44L. López Díaz45P. Mir46P. Martinez-Martin47COPPADIS Study Group48CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, SpainCHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, SpainCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, SpainCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, SpainCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, SpainCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, SpainCHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, SpainUnidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, SpainHospital Universitari Mutua de Terrassa, Terrassa, SpainHospital Universitari Mutua de Terrassa, Terrassa, SpainHospital Clínic de Barcelona, Barcelona, SpainHospital Clínic de Barcelona, Barcelona, SpainCentro Neurológico Oms 42, Palma de Mallorca, SpainConsorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, SpainHospital Universitario Son Espases, Palma de Mallorca, SpainHospital Universitario Vall d´Hebron, Barcelona, SpainComplejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, SpainHospital Universitario La Princesa, Madrid, SpainCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, SpainConsorci Sanitari Integral, Hospital General de L´Hospitalet, L´Hospitalet de Llobregat, Barcelona, SpainHospital Universitario Clínico San Carlos, Madrid, SpainHospital Da Costa, Burela, Lugo, SpainHospital del Mar, Barcelona, SpainHospital Universitario Virgen Macarena, Sevilla, SpainHospital Infanta Sofía, Madrid, SpainInstitut d'Assistència Sanitària (IAS) - Institut Català de la Salut, Girona, SpainHospital General Universitario de Elche, Elche, SpainFundación Hospital de Alcorcón, Madrid, SpainHospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, SpainComplejo Asistencial Universitario de Burgos, Burgos, SpainHospital Universitario de Canarias, San Cristóbal de la Laguna, Santa Cruz de Tenerife, SpainHospital Universitario Ramón y Cajal, Madrid, SpainHospital Universitario Puerta de Hierro, Madrid, SpainHospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, SpainComplejo Hospitalario de Toledo, Toledo, SpainComplejo Hospitalario de Navarra, Pamplona, SpainCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, SpainHospital Universitario Central de Asturias, Oviedo, SpainComplejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, SpainHospital Universitario Donostia, San Sebastián, SpainHospital Arnau de Vilanova, Valencia, SpainHospital Ruber Internacional, Madrid, SpainHospital Universitario Vall d´Hebron, Barcelona, SpainHospital Universitario Lucus Augusti (HULA), Lugo, SpainHospital Rey Juan Carlos, Madrid, SpainComplejo Hospitalario Universitario de Orense (CHUO), Orense, SpainUnidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, SpainCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, SpainFundación Curemos el Parkinson, C/Juana de Vega 23 2°, A Coruña 15004, SpainIntroduction. In a degenerative disorder such as Parkinson’s disease (PD), it is important to establish clinical stages that allow to know the course of the disease. Our aim was to analyze whether a scale combining Hoehn and Yahr’s motor stage (H&Y) and the nonmotor symptoms burden (NMSB) (assessed by the nonmotor symptoms scale (NMSS)) provides information about the disability and the patient’s quality of life (QoL) with regard to a defined clinical stage. Materials and Methods. Cross-sectional study in which 603 PD patients from the COPPADIS cohort were classified according to H&Y (1, stage I; 2, stage II; 3, stage III; 4, stage IV/V) and NMSB (A: NMSS = 0–20; B: NMSS = 21–40; C: NMSS = 41–70; D: NMSS ≥ 71) in 16 stages (HY.NMSB, from 1A to 4D). QoL was assessed with the PDQ-39SI, PQ-10, and EUROHIS-QOL8 and disability with the Schwab&England ADL (Activities of Daily Living) scale. Results. A worse QoL and greater disability were observed at a higher stage of H&Y and NMSB (p<0.0001). Combining both (HY.NMSB), patients in stages 1C and 1D and 2C and 2D had significantly worse QoL and/or less autonomy for ADL than those in stages 2A and 2B and 3A and 3B, respectively (p<0.005; e.g., PDQ-39SI in 1D [n = 15] vs 2A [n = 101]: 28.6 ± 17.1 vs 7.9 ± 5.8; p<0.0001). Conclusion. The HY.NMSB scale is simple and reflects the degree of patient involvement more accurately than the H&Y. Patients with a lower H&Y stage may be more affected if they have a greater NMS burden.http://dx.doi.org/10.1155/2021/8871549
spellingShingle D. Santos García
T. De Deus Fonticoba
J. M. Paz González
C. Cores Bartolomé
L. Valdés Aymerich
J. G. Muñoz Enríquez
E. Suárez
S. Jesús
M. Aguilar
P. Pastor
L. L. Planellas
M. Cosgaya
J. García Caldentey
N. Caballol
I. Legarda
J. Hernández Vara
I. Cabo
L. López Manzanares
I. González Aramburu
M. A. Ávila Rivera
M. J. Catalán
V. Nogueira
V. Puente
J. M. García Moreno
C. Borrué
B. Solano Vila
M. Álvarez Sauco
L. Vela
S. Escalante
E. Cubo
F. Carrillo Padilla
J. C. Martínez Castrillo
P. Sánchez Alonso
M. G. Alonso Losada
N. López Ariztegui
I. Gastón
J. Kulisevsky
M. Blázquez Estrada
M. Seijo
J. Rúiz Martínez
C. Valero
M. Kurtis
O. de Fábregues
J. González Ardura
C. Ordás
L. López Díaz
P. Mir
P. Martinez-Martin
COPPADIS Study Group
Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
Parkinson's Disease
title Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
title_full Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
title_fullStr Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
title_full_unstemmed Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
title_short Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
title_sort staging parkinson s disease combining motor and nonmotor symptoms correlates with disability and quality of life
url http://dx.doi.org/10.1155/2021/8871549
work_keys_str_mv AT dsantosgarcia stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT tdedeusfonticoba stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jmpazgonzalez stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT ccoresbartolome stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT lvaldesaymerich stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jgmunozenriquez stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT esuarez stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT sjesus stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT maguilar stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT ppastor stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT llplanellas stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT mcosgaya stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jgarciacaldentey stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT ncaballol stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT ilegarda stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jhernandezvara stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT icabo stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT llopezmanzanares stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT igonzalezaramburu stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT maavilarivera stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT mjcatalan stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT vnogueira stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT vpuente stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jmgarciamoreno stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT cborrue stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT bsolanovila stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT malvarezsauco stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT lvela stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT sescalante stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT ecubo stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT fcarrillopadilla stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jcmartinezcastrillo stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT psanchezalonso stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT mgalonsolosada stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT nlopezariztegui stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT igaston stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jkulisevsky stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT mblazquezestrada stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT mseijo stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jruizmartinez stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT cvalero stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT mkurtis stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT odefabregues stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT jgonzalezardura stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT cordas stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT llopezdiaz stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT pmir stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT pmartinezmartin stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife
AT coppadisstudygroup stagingparkinsonsdiseasecombiningmotorandnonmotorsymptomscorrelateswithdisabilityandqualityoflife